Ariad Pharmaceuticals Inc. Research Report
On January 2, 2014, Ariad Pharmaceuticals Inc. (Ariad) announced that it will be presenting at the 32nd Annual J.P. Morgan Healthcare Conference to be held in San Francisco. The Company stated that its Chairman and CEO, Harvey J. Berger, M.D., will provide the Company's business overview on Tuesday, January 14, 2014 at 3:00 p.m. PT. Ariad added that the presentation will be webcast live and can be accessed via the Investor Relations section of the Company's website, with a replay of the presentation to be available and archived on the website for three weeks. The Full Research Report on Ariad Pharmaceuticals Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
analystscorner.com/microwriter/link.php's=DDD
www.finanznachrichten.de/...olina-mednax-and-merrimack-008.htm